Literature DB >> 29082807

Barbed sutures versus conventional sutures for uterine closure at cesarean section; a randomized controlled trial.

Mohamed A Zayed1, Usama M Fouda1, Khaled A Elsetohy1, Shereef M Zayed1, Ahmed T Hashem1, Mohamed A Youssef1.   

Abstract

INTRODUCTION: The aim of this randomized control trial was to compare the operative data and the early postoperative outcomes of cesarean sections in which the uterine incision was closed with a barbed suture (STRATAFIX™ Spiral PDO Knotless Tissue Control Device, SXPD2B405, Ethicon Inc.) with those of cesarean sections in which the uterine incision was closed with a conventional smooth suture (VICRYL™; Ethicon Inc.).
MATERIALS AND METHODS: One hundred pregnant patients were randomized in a 1:1 ratio to the Stratafix group or the Vicryl group. The uterine incision was closed by two layers of sutures in both groups. In the Vicryl group, the first layer was continuous and the second layer was interrupted. In the Stratafix group, both layers were continuous.
RESULTS: The uterine closure time was significantly lower in the Stratafix group (224 ± 46 versus 343 ± 75 s, p < .001). Operative time was comparable between both groups. Twelve patients in the Vicryl group and two patients in the Stratafix group required additional sutures to achieve hemostasis (p value = .009). The mean blood loss during closure of uterine incision and mean hospital stay were lower in the Stratafix group but these differences failed to reach statistical significance.
CONCLUSION: The use of barbed suture for uterine incision closure at cesarean section is associated with shorter uterine closure time and similar early perioperative complications compared with conventional smooth suture. The difference between both groups in the technique of suturing the second layer of the uterine incision may be the cause of the reduction in the uterine closure time and the need for additional sutures to achieve hemostasis during suturing the uterine incision with a barbed suture. Further, well designed randomized controlled trials should be conducted to investigate the association between the type of suture (barbed or conventional smooth) and remote complications of cesarean section (infertility, pelvic pain, abnormal placentation and rupture uterus).

Entities:  

Keywords:  Barbed sutures; Stratafix; Vicryl; cesarean section

Mesh:

Year:  2017        PMID: 29082807     DOI: 10.1080/14767058.2017.1388368

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Laparoscopic inguinal herniorrhaphy with barbed suture in a ram.

Authors:  Benjamin T Jakobek; Rebecca C McOnie; Susan L Fubini; Galina Hayes
Journal:  Can Vet J       Date:  2021-12       Impact factor: 1.008

2.  Surgical benefits of bidirectional knotless barbed sutures over conventional sutures for uterine repair during cesarean section-A meta-analysis of randomized controlled trials.

Authors:  Preeti Deedwania; Abhishek Singh; Tejas Patel
Journal:  Turk J Obstet Gynecol       Date:  2022-03-28

3.  Comparison of the effect of skin closure materials on skin closure during cesarean delivery.

Authors:  Ye Huang; Xinbo Yin; Junni Wei; Suhong Li
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

4.  New Continuous Barbed Suture Device with Stratafix for the Vaginal Stump in Laparoscopic Hysterectomy.

Authors:  Shintaro Yanazume; Shinichi Togami; Mika Fukuda; Toshihiko Kawamura; Masaki Kamio; Shunichiro Ota; Hiroaki Kobayashi
Journal:  Gynecol Minim Invasive Ther       Date:  2018-09-26

5.  The Case for Standardizing Cesarean Delivery Technique: Seeing the Forest for the Trees.

Authors:  Joshua D Dahlke; Hector Mendez-Figueroa; Lindsay Maggio; Jeffrey D Sperling; Suneet P Chauhan; Dwight J Rouse
Journal:  Obstet Gynecol       Date:  2020-11       Impact factor: 7.623

6.  A comparison of barbed continuous suture versus conventional interrupted suture for fascial closure in total hip arthroplasty.

Authors:  Sunhyung Lee; Taehong Kee; Mi Yeon Jung; Pil Whan Yoon
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.